<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2021-12-03</periodOfReport>

    <notSubjectToSection16>1</notSubjectToSection16>

    <issuer>
        <issuerCik>0001835567</issuerCik>
        <issuerName>Pear Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>PEAR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001489216</rptOwnerCik>
            <rptOwnerName>Miller Henry S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O THIMBLE POINT ACQUISITION CORP.</rptOwnerStreet1>
            <rptOwnerStreet2>195 CHURCH STREET, 15TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW HAVEN</rptOwnerCity>
            <rptOwnerState>CT</rptOwnerState>
            <rptOwnerZipCode>06510</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>1</isOther>
            <otherText>See Remarks</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <footnotes></footnotes>

    <remarks>On December 3, 2021, Thimble Point Acquisition Corp. (&quot;THMA&quot; and the former name of the Issuer) consummated an initial business combination (the &quot;Business Combination&quot;) with Pear Therapeutics, Inc. The Reporting Person resigned as a director of THMA immediately prior to the consummation of the Business Combination.</remarks>

    <ownerSignature>
        <signatureName>/s/ Joseph Iannotta as Attorney-in-Fact</signatureName>
        <signatureDate>2021-12-06</signatureDate>
    </ownerSignature>
</ownershipDocument>
